Distinct muscarinic acetylcholine receptor subtypes mediate pre- and postsynaptic effects in rat neocortex

BMC Neuroscience

Volumn 13, Issue 1, 2012, Pages

  Gigout, Sylvain ^a   Jones, Gareth A ^b   Wierschke, Stephan ^a   Davies, Ceri H ^b   Watson, Jeannette M ^b   Deisz, Rudolf A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Carbachol; Cognition; M current; Muscarinic acetylcholine receptors; Sensorimotor cortex; Synaptic transmission

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; ATROPINE; CARBACHOL; LINOPIRDINE; MUSCARINIC RECEPTOR; OTENZEPAD; PIRENZEPINE; RECEPTOR SUBTYPE; XANOMELINE;

ANIMAL TISSUE; ARTICLE; ATTENTION; BRAIN SLICE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; LEARNING; LONG TERM POTENTIATION; MALE; NEOCORTEX; NONHUMAN; RAT; SIGNAL NOISE RATIO; SYNAPTIC TRANSMISSION;

ACTION POTENTIALS; ANIMALS; BIOPHYSICS; CHOLINERGIC AGONISTS; DRUG INTERACTIONS; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; GAMMA-AMINOBUTYRIC ACID; MALE; NEOCORTEX; NEURAL INHIBITION; PROTEIN SUBUNITS; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84862223300     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-13-42     Document Type: Article

References (53)

1. Wess J. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol 2004, 44:423-450. 10.1146/annurev.pharmtox.44.101802.121622, 14744253.
2. Freedman R, Adler LE, Bickford P, Byerley W, Coon H, Cullum CM, Griffith JM, Harris JG, Leonard S, Miller C, et al. Schizophrenia and nicotinic receptors. Harv Rev Psychiatry 1994, 2(4):179-192. 10.3109/10673229409017136, 9384901.
3. Harbaugh RE, Roberts DW, Coombs DW, Saunders RL, Reeder TM. Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease. Neurosurgery 1984, 15(4):514-518. 10.1227/00006123-198410000-00007, 6149490.
4. Minzenberg MJ, Poole JH, Benton C, Vinogradov S. Association of anticholinergic load with impairment of complex attention and memory in schizophrenia. Am J Psychiatry 2004, 161(1):116-124. 10.1176/appi.ajp.161.1.116, 14702259.
5. Fisher A. Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease. Neurotherapeutics 2008, 5(3):433-442. 10.1016/j.nurt.2008.05.002, 18625455.
6. Pepeu G, Giovannini MG. Cholinesterase inhibitors and beyond. Curr Alzheimer Res 2009, 6(2):86-96. 10.2174/156720509787602861, 19355843.
7. Caulfield MP, Birdsall NJM. International union of pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 1998, 50(2):279-290.
8. Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J, Capon DJ. Distinct primary structures, ligand-binding properties and tissue-specific expression of 4 human muscarinic acetylcholine-receptors. EMBO J 1987, 6(13):3923-3929. 553870, 3443095.
9. Delmas P, Brown DA. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat Rev Neurosci 2005, 6(11):850-862.
10. Langmead CJ, Watson J, Reavill C. Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol Ther 2008, 117(2):232-243. 10.1016/j.pharmthera.2007.09.009, 18082893.
11. Clader JW, Wang Y. Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's disease. Curr Pharm Des 2005, 11(26):3353-3361. 10.2174/138161205774370762, 16250841.
12. Olianas MC, Dedoni S, Ambu R, Onali P. Agonist activity of N-desmethylclozapine at delta-opioid receptors of human frontal cortex. Eur J Pharmacol 2009, 607(1-3):96-101.
13. Fleming JJ, England PM. Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands. Bioorg Med Chem 2010, 18(4):1381-1387. 10.1016/j.bmc.2009.12.072, 20096591.
14. Thomas DR, Dada A, Jones GA, Deisz RA, Gigout S, Langmead CJ, Werry TD, Hendry N, Hagan JJ, Davies CH, et al. N-desmethylclozapine (NDMC) is an antagonist at the human native muscarinic M1 receptor. Neuropharmacology 2010, 58(8):1206-1214. 10.1016/j.neuropharm.2010.02.017, 20206188.
15. Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 1991, 11(10):3218-3226.
16. Mrzljak L, Levey AI, Belcher S, Goldman-Rakic PS. Localization of the m2 muscarinic acetylcholine receptor protein and mRNA in cortical neurons of the normal and cholinergically deafferented rhesus monkey. J Comp Neurol 1998, 390(1):112-132. 10.1002/(SICI)1096-9861(19980105)390:1<112::AID-CNE10>3.0.CO;2-Z, 9456180.
17. Mrzljak L, Levey AI, Goldman-Rakic PS. Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission. Proc Natl Acad Sci USA 1993, 90(11):5194-5198. 10.1073/pnas.90.11.5194, 46682, 8389473.
18. Disney AA, Domakonda KV, Aoki C. Differential expression of muscarinic acetylcholine receptors across excitatory and inhibitory cells in visual cortical areas V1 and V2 of the macaque monkey. J Comp Neurol 2006, 499(1):49-63. 10.1002/cne.21096, 16958109.
19. Krnjevic K, Pumain R, Renaud L. The mechanism of excitation by acetylcholine in the cerebral cortex. J Physiol (Lond) 1971, 215(1):247-268.
20. McCormick DA, Williamson A. Convergence and divergence of neurotransmitter action in human cerebral cortex. Proc Natl Acad Sci USA 1989, 86(20):8098-8102. 10.1073/pnas.86.20.8098, 298222, 2573061.
21. Carr DB, Surmeier DJ. M1 muscarinic receptor modulation of Kir2 channels enhances temporal summation of excitatory synaptic potentials in prefrontal cortex pyramidal neurons. J Neurophysiol 2007, 97(5):3432-3438. 10.1152/jn.00828.2006, 17376848.
22. Levy RB, Reyes AD, Aoki C. Nicotinic and muscarinic reduction of unitary excitatory postsynaptic potentials in sensory cortex; Dual intracellular recording in vitro. J Neurophysiol 2006, 95(4):2155-2166. 1409808, 16421199.
23. Salgado H, Bellay T, Nichols JA, Bose M, Martinolich L, Perrotti L, Atzori M. Muscarinic M2 and M1 receptors reduce GABA release by Ca2+ channel modulation through activation of PI3K/Ca2+-independent and PLC/Ca2+-dependent PKC. J Neurophysiol 2007, 98(2):952-965. 10.1152/jn.00060.2007, 17581851.
24. Shannon HE, Rasmussen K, Bymaster FP, Hart JC, Peters SC, Swedberg MDB, Jeppesen L, Sheardown MJ, Sauerberg P, Fink-Jensen A. Xanomeline, an M1/M4 preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice. Schizophrenia Research 2000, 42(3):249-259. 10.1016/S0920-9964(99)00138-3, 10785583.
25. Aiken SP, Lampe BJ, Murphy PA, Brown BS. Reduction of spike frequency adaptation and blockade of M-current in rat CA1 pyramidal neurones by linopirdine (DuP 996), a neurotransmitter release enhancer. Br J Pharmacol 1995, 115(7):1163-1168. 10.1111/j.1476-5381.1995.tb15019.x, 1908770, 7582539.
26. Rundfeldt C. The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells. Eur J Pharmacol 1997, 336(2-3):243-249.
27. Luhmann HJ, Mittmann T, Vanluijtelaar G, Heinemann U. Impairment of intracortical GABAergic inhibition in a rat model of absence epilepsy. Epilepsy Res 1995, 22(1):43-51. 10.1016/0920-1211(95)00032-6, 8565966.
28. Reid KH, Edmonds HL, Schurr A, Tseng MT, West CA. Pitfalls in the use of brain slices. Prog Neurobiol 1988, 31(1):1-18. 10.1016/0301-0082(88)90020-2, 3287453.
29. Thompson SM, Deisz RA, Prince DA. Relative contributions of passive equilibrium and active transport to the distribution of chloride in mammalian cortical neurons. J Neurophysiol 1988, 60(1):105-24.
30. McCormick DA, Prince DA. Two types of muscarinic response to acetylcholine in mammalian cortical neurons. Proc Natl Acad Sci USA 1985, 82(18):6344-6348. 10.1073/pnas.82.18.6344, 391050, 3862134.
31. Xiao Z, Deng PY, Yang C, Lei S. Modulation of GABAergic transmission by muscarinic receptors in the entorhinal cortex of juvenile rats. J Neurophysiol 2009, 102(2):659-669. 10.1152/jn.00226.2009, 2724340, 19494196.
32. Yoshida M, Alonso A. Cell-type specific modulation of intrinsic firing properties and subthreshold membrane oscillations by the M(Kv7)-current in neurons of the entorhinal cortex. J Neurophysiol 2007, 98(5):2779-2794. 10.1152/jn.00033.2007, 17728392.
33. Shen W, Hamilton SE, Nathanson NM, Surmeier DJ. Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons. J Neurosci 2005, 25(32):7449-7458. 10.1523/JNEUROSCI.1381-05.2005, 16093396.
34. Hamam BN, Sinai M, Poirier G, Chapman CA. Cholinergic suppression of excitatory synaptic responses in layer II of the medial entorhinal cortex. Hippocampus 2007, 17(2):103-113. 10.1002/hipo.20249, 17146776.
35. Sheridan RD, Sutor B. Presynaptic M1 muscarinic cholinoceptors mediate inhibition of excitatory synaptic transmission in the hippocampus in vitro. Neurosci Lett 1990, 108(3):273-278. 10.1016/0304-3940(90)90653-Q, 2304648.
36. De Fernandez Sevilla D, Rodrigo-Angulo M, Nunez A, Buno W. Cholinergic modulation of synaptic transmission and postsynaptic excitability in the rat gracilis dorsal column nucleus. J Neurosci 2006, 26(15):4015-4025. 10.1523/JNEUROSCI.5489-05.2006, 16611818.
37. Gulledge AT, Bucci DJ, Zhang SS, Matsui M, Yeh HH. M1 receptors mediate cholinergic modulation of excitability in neocortical pyramidal neurons. J Neurosci 2009, 29(31):9888-9902. 10.1523/JNEUROSCI.1366-09.2009, 2745329, 19657040.
38. Hamilton SE, Loose MD, Qi M, Levey AI, Hille B, McKnight GS, Idzerda RL, Nathanson NM. Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Natl Acad Sci U S A 1997, 94(24):13311-13316. 10.1073/pnas.94.24.13311, 24305, 9371842.
39. Deisz RA. The GABAB receptor antagonist CGP 55845A reduces presynaptic GABAB actions in neocortical neurons of the rat in vitro. Neuroscience 1999, 93(4):1241-1249. 10.1016/S0306-4522(99)00203-1, 10501448.
40. Deisz RA, Prince DA. Frequency-dependent depression of inhibition in guinea-pig neocortex in vitro by GABAB receptor feed-back on GABA release. J Physiol (Lond) 1989, 412:513-541.
41. Yamasaki M, Matsui M, Watanabe M. Preferential localization of muscarinic M1 receptor on dendritic shaft and spine of cortical pyramidal cells and its anatomical evidence for volume transmission. J Neurosci 2010, 30(12):4408-4418. 10.1523/JNEUROSCI.5719-09.2010, 20335477.
42. Richter M, Schilling T, Muller W. Muscarinic control of intracortical connections to layer II in rat entorhinal cortex slice. Neurosci Lett 1999, 273(3):200-202. 10.1016/S0304-3940(99)00643-6, 10515193.
43. Moriya H, Takagi Y, Nakanishi T, Hayashi M, Tani T, Hirotsu I. Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland. Life Sci 1999, 64(25):2351-2358. 10.1016/S0024-3205(99)00188-5, 10374898.
44. Caulfield MP. Muscarinic receptors - Characterization, coupling and function. Pharmacol Ther 1993, 58(3):319-379. 10.1016/0163-7258(93)90027-B, 7504306.
45. Lanzafame AA, Christopoulos A, Mitchelson F. Cellular signaling mechanisms for muscarinic acetylcholine receptors. Recept Channels 2003, 9(4):241-260. 10.1080/10606820308263, 12893537.
46. Dasari S, Gulledge AT. M1 and M4 receptors modulate hippocampal pyramidal neurons. J Neurophysiol 2011, 105(2):779-792. 10.1152/jn.00686.2010, 3059175, 21160001.
47. Davies CH, Starkey SJ, Pozza MF, Collingridge GL. GABA autoreceptors regulate the induction of LTP. Nature 1991, 349(6310):609-611. 10.1038/349609a0, 1847993.
48. Hasselmo ME, McGaughy J. High acetylcholine levels set circuit dynamics for attention and encoding and low acetylcholine levels set dynamics for consolidation. Prog Brain Res 2004, 145:207-231.
49. Buckley NJ, Bonner TI, Buckley CM, Brann MR. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 1989, 35(4):469-476.
50. Alkondon M, Pereira EFR, Almeida LEF, Randall WR, Albuquerque EX. Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus. Neuropharmacology 2000, 39(13):2726-2739. 10.1016/S0028-3908(00)00156-8, 11044743.
51. Dutar P, Nicoll RA. Classification of muscarinic responses in hippocampus in terms of receptor subtypes and second-messenger systems: electrophysiological studies in vitro. J Neurosci 1988, 8(11):4214-4224.
52. Teichgraber LA, Lehmann TN, Meencke HJ, Weiss T, Nitsch R, Deisz RA. Impaired function of GABAB receptors in tissues from pharmacoresistant epilepsy patients. Epilepsia 2009, 50(7):1697-1716. 10.1111/j.1528-1167.2009.02094.x, 19453710.
53. Connors BW, Gutnick MJ. Intrinsic firing patterns of diverse neocortical neurons. Trends Neurosci 1990, 13(3):99-104. 10.1016/0166-2236(90)90185-D, 1691879.